Search

Marina Y Gelman

from San Francisco, CA
Age ~65
Get Report
Also known as:
Mikhail Gelman, Martina Gelman, Martin A Gelman, Marlna Gelman, Mapina Gelman, Marina Galman
Phone and address:
1785 Broadway, San Francisco, CA 94109
Related to:
Adam A Gelman, 35Mikhail Gelman, 83Micheala GelmanNicole M Gelman, 29
Connected to:
Allen Gelman, 71Ashley R Gelman, 34Barbara C Gelman, 66Clifford L Gelman, 62Dove N Gelman, 50Eduard Gelman, 83Edward Gelman, 53Elena R Gelman, 51Fima Gelman, 70Irene Gelman, 89

Marina Gelman Phones & Addresses

  • 1785 Broadway, San Francisco, CA 94109
  • 1787 Broadway, San Francisco, CA 94109
  • 1226 Chestnut St, San Francisco, CA 94109 (415) 567-6462
  • 1601 Pacific Ave, San Francisco, CA 94109 (415) 440-0888
  • 1946 California St, San Francisco, CA 94109
  • Novato, CA
  • Walnut Creek, CA
  • Mc Carr, KY

Resumes

Resumes

Marina Gelman Photo 1

Diretor De Relaã Ães Institucionais

View page
Location:
New York, NY
Industry:
Think Tanks
Work:
Anima Educacao
Diretor De Relaã Ães Institucionais
Fgv Oct 2012 - Apr 2013
Assistente Da Coordenadoria Do Programa De Mestrado Profissional
Cia Melhoramentos De São Paulo 2001 - 2011
Diretora Jurã Dica
Machado Associados Sep 1999 - Dec 2000
Advogada Associada
Lacaz Martins, Pereira Neto, Gurevich & Schoueri Advogados Apr 1994 - Aug 1999
Advogada
Education:
Pontifícia Universidade Católica De São Paulo 1992 - 1996
Colégio Nossa Senhora Do Morumbi 1990
Skills:
Mergers and Acquisitions
Strategic Planning
Due Diligence
Corporate Law
Planejamento Empresarial
Negotiation
Joint Ventures
Marketing Strategy
Interests:
Children
Arts and Culture
Education
Languages:
Spanish
English
Portugese
Marina Gelman Photo 2

Senior Software Qa Engineer

View page
Location:
San Francisco, CA
Industry:
Telecommunications
Work:
Alcatel-Lucent
Sr. Software QA Engineer
Avantos Performance System 1996 - 1996
Quality Assurance Engineer
Education:
Kiev State Pedagogical University 1976 - 1981
Skills:
Software Quality Assurance
Quality Assurance
Ip
Testing
Test Automation
Tcp/Ip
Agile Methodologies
Enterprise Software
Languages:
Ukrainian
Russian
English
Marina Gelman Photo 3

Executive Assistant To Chief Executive Officer And Office Manager And Company Event Planner

View page
Location:
3131 Vicente St, San Francisco, CA 94116
Industry:
Computer Software
Work:
Arxan Technologies
Executive Assistant To Chief Executive Officer and Office Manager and Company Event Planner
Argyle Data Sep 2014 - Oct 2016
Executive Assistant To Chief Executive Officer and Office Manager
Metacafe Jan 2010 - Dec 2013
Contractor - Office Manager
Former Ceo of Opentv Aug 2008 - Aug 2013
Executive Assistant To Former Chief Executive Officer of Opentv - Part Time
Opentv Sep 2005 - 2008
Executive Assistant To Chief Executive Officer
Skills:
Start Ups
E Commerce
Team Building
Management
Product Management
Crm
Cloud Computing
Sourcing
Program Management
Business Development
Salesforce.com
Product Marketing
Saas
Strategic Partnerships
Business Intelligence
Mergers and Acquisitions
Languages:
English
Russian
Marina Gelman Photo 4

Director Of Translational Science

View page
Location:
248 26Th Ave, San Francisco, CA 94121
Industry:
Biotechnology
Work:
Calithera Biosciences
Director of Translational Science
Rigel Pharmaceuticals Inc. Jan 2009 - Sep 2016
Senior Director
Rigel Pharmaceuticals Inc. Jan 2004 - Dec 2008
Project Leader
Ppd Mar 2002 - Aug 2003
Research Scientist
Stanford University Mar 1997 - Mar 2002
Posdoctoral Fellow
Education:
Stony Brook University 1991 - 1997
Doctorates, Doctor of Philosophy, Biology, Pharmacology
Skills:
Drug Discovery
Assay Development
Oncology
Clinical Development
Cell Biology
Biotechnology
Molecular Biology
Lead Change
Genomics
Immunology
Technology Transfer
Drug Development
Biochemistry
Medicinal Chemistry
Life Sciences
Pharmaceutical Industry
Ind
Lifesciences
Research and Development
Animal Models
Cell Culture
Cell Signaling
R&D
Product Management
Interests:
Kids
Cruises
Traveling
Sweepstakes
Investing
Home Improvement
International Traavel
Electronics
Reading
Crafts
Music
Travel
Movies
Collecting
Home Decoration
Languages:
English
Russian
Marina Gelman Photo 5

Senior Sowtware Qa Engineer

View page
Location:
San Francisco, CA
Work:
Genesys
Senior Sowtware Qa Engineer
Marina Gelman Photo 6

Marina Gelman

View page
Marina Gelman Photo 7

Marina Gelman

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Marina Gelman
Owner
1887 Dance Shop
Ret Dance Wear
2206 Un St, San Francisco, CA 94123
(415) 441-1887
Marina Gelman
Executive
OPENTV, INC
Prepackaged Software Services · Custom Computer Programing · Custom Computer Programming Services · Cable/Pay Television Service · Software Publishers · Other Electronic Parts and Equipment Merchant Wholesalers
275 Sacramento St, San Francisco, CA 94111
1726 Cole Blvd, Denver, CO 80401
(415) 962-5000

Publications

Us Patents

Pyrimidinediamine Kinase Inhibitors

View page
US Patent:
8278299, Oct 2, 2012
Filed:
Dec 29, 2009
Appl. No.:
12/649073
Inventors:
Rajinder Singh - Belmont CA, US
Andy Atuegbu - Dublin CA, US
John Ramphal - Union City CA, US
Hui Li - Santa Clara CA, US
Marina Gelman - San Francisco CA, US
Jeffrey Clough - Redwood City CA, US
Carlos Valdez - San Ramon CA, US
Somasekhar Bhamidipati - Foster City CA, US
Sambaiah Thota - Woburn MA, US
Darren McMurtrie - Foster City CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07D 413/14
C07D 417/14
A61K 31/5415
A61K 31/538
US Classification:
5142305, 544105
Abstract:
The present invention provides pyrimidinediamine compounds useful for inhibiting kinase activity, including the activity of polo-like kinase 1 (PLK1). Also provided are pharmaceutical compositions comprising these compounds and methods of treating diseases associated with kinase activity, in particular enhanced PLK1 catalytic activity, such as diseases associated with abnormal cell proliferation, including neoplastic disorders.

Pyrimidinediamine Kinase Inhibitors

View page
US Patent:
8518937, Aug 27, 2013
Filed:
Sep 11, 2012
Appl. No.:
13/610569
Inventors:
Rajinder Singh - Belmont CA, US
Andy Atuegbu - Dublin CA, US
John Ramphal - Union City CA, US
Hui Li - Santa Clara CA, US
Marina Gelman - San Francisco CA, US
Jeffrey Clough - Redwood City CA, US
Carlos Valdez - San Ramon CA, US
Somasekhar Bhamidipati - Foster City CA, US
Sambaiah Thota - Woburn MA, US
Darren McMurtrie - Foster City CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07D 498/04
C07D 413/04
C07D 413/14
A61K 31/5415
A61K 31/538
US Classification:
5142305, 544320, 544105
Abstract:
Disclosed embodiments provide pyrimidinediamine compounds useful for inhibiting kinase activity, including the activity of polo-like kinase 1 (PLK1). Also disclosed are pharmaceutical compositions comprising these compounds and methods of treating diseases associated with kinase activity, in particular enhanced PLK1 catalytic activity, such as diseases associated with abnormal cell proliferation, including neoplastic disorders.

Targets For Controlling Cellular Growth And For Diagnostic Methods

View page
US Patent:
20050003390, Jan 6, 2005
Filed:
Feb 26, 2004
Appl. No.:
10/789378
Inventors:
Sergey Axenovich - San Jose CA, US
Robert Stull - Alameda CA, US
Marina Gelman - San Francisco CA, US
Kitty Chui - San Francisco CA, US
Dean Ng - Foster City CA, US
International Classification:
C12Q001/68
G01N033/574
US Classification:
435006000, 435007230
Abstract:
A method of identifying a compound that induces apoptosis is disclosed. The method includes identifying compounds that inhibit the expression and/or activity of a target. Also disclosed are methods for inducing apoptosis by inhibiting one of the targets. The invention further includes methods for the diagnosis of a tumor that include determining the level of at least one of the targets as a biomarker in a patient sample, the level of the biomarker being indicative of the presence of tumor cells.

Pyrimidinediamine Kinase Inhibitors

View page
US Patent:
20130309228, Nov 21, 2013
Filed:
Jul 23, 2013
Appl. No.:
13/948342
Inventors:
Andy Atuegbu - Dublin CA, US
John Ramphal - Union City CA, US
Hui Li - Santa Clara CA, US
Marina Gelman - San Francisco CA, US
Jeffrey Clough - Redwood City CA, US
Carlos Valdez - San Ramon CA, US
Somasekhar Bhamidipati - Foster City CA, US
Sambaiah Thota - Woburn MA, US
Darren McMurtrie - Foster City CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 31/5383
A61K 45/06
US Classification:
4241331, 544105, 5142305
Abstract:
Disclosed embodiments provide pyrimidinediamine compounds useful for inhibiting kinase activity, including the activity of polo-like kinase 1 (PLK1). Also disclosed are pharmaceutical compositions comprising these compounds and methods of treating diseases associated with kinase activity, in particular enhanced PLK1 catalytic activity, such as diseases associated with abnormal cell proliferation, including neoplastic disorders.

2,3-Disubstituted Pyridine Compounds As Tgf-Beta Inhibitors And Methods Of Use

View page
US Patent:
20190284155, Sep 19, 2019
Filed:
Jan 16, 2019
Appl. No.:
16/249458
Inventors:
- South San Francisco CA, US
Somasekhar Bhamidipati - Foster City CA, US
Pingyu Ding - Foster City CA, US
Donald Payan - Hillsborough CA, US
Marina Gelman - San Francisco CA, US
Todd Kinsella - Redwood City CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07D 401/04
A61K 31/4439
C07D 401/14
A61K 45/06
A61K 39/395
C07D 405/14
C07F 7/08
C07K 16/28
A61K 31/444
A61K 31/517
A61K 31/519
A61K 31/5377
A61K 31/635
A61K 31/695
C07D 487/04
C07D 471/04
C07D 417/14
C07D 417/04
Abstract:
The invention described herein comprises compounds and a method of treating cancer comprising administering to a subject having cancer one of the compounds in conjunction with another therapeutic treatment of cancer. The compounds inhibit signaling by a member of the TGF-β superfamily such as Nodal or Activin

Fused Imidazole Derivatives As Tgf-Beta Inhibitors

View page
US Patent:
20180346487, Dec 6, 2018
Filed:
Nov 16, 2015
Appl. No.:
15/527908
Inventors:
- South San Francisco CA, US
Todd Kinsella - Redwood City CA, US
Jiaxin Yu - Foster City CA, US
Marina Gelman - San Francisco CA, US
Ihab S. Darwish - San Carlos CA, US
International Classification:
C07D 519/00
C07D 487/04
C07D 498/04
A61K 45/06
A61K 31/437
A61K 31/4365
A61K 31/428
A61K 31/4709
A61K 31/498
A61K 31/517
A61K 31/5377
A61K 31/4188
A61K 31/416
A61K 31/519
Abstract:
Disclosed are imidazole compounds, as well as pharmaceutical compositions and methods of use thereof. One embodiment is a compound having the structure Formula (I) and pharmaceutically acceptable salts, prodrugs and N-oxides thereof (and solvates and hydrates thereof), wherein A, Z, X, R, Rm, p and a are as described herein. In certain embodiments, a compound disclosed herein inhibits TGF-β, and can be used to treat disease by blocking TGF-β signaling.

Gdf-8 Inhibitors

View page
US Patent:
20170342048, Nov 30, 2017
Filed:
Jul 13, 2017
Appl. No.:
15/366981
Inventors:
- South San Francisco CA, US
Marina Gelman - San Francisco CA, US
Pingyu Ding - Foster City CA, US
Rajinder Singh - Belmont CA, US
Jeffrey Clough - Redwood City CA, US
Todd Kinsella - Redwood City CA, US
Donald Payan - Hillsborough CA, US
International Classification:
C07D 401/04
C07D 513/04
C07D 498/04
C07D 487/04
C07D 471/04
C07D 417/14
C07D 213/26
C07D 417/04
C07D 413/04
C07D 405/14
C07D 405/04
C07D 401/14
C07F 9/6503
C07D 453/02
Abstract:
Described are GCF-8 inhibitors of the formula (I),and pharmaceutically acceptable salts thereof, wherein n, R, R, R, R, X and Z are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for inhibiting GDF-8 in a cell and methods for treating a patient suffering from a disease or disorder, wherein the patient would therapeutically benefit from an increase in mass or strength of muscle tissue.

2,3-Disubstituted Pyridine Compounds As Tgf-Beta Inhibitors And Methods Of Use

View page
US Patent:
20170096409, Apr 6, 2017
Filed:
Apr 2, 2015
Appl. No.:
15/128051
Inventors:
- South San Francisco CA, US
Somasekhar Bhamidipati - Foster City CA, US
Pingyu Ding - Foster City CA, US
Donald Payan - Hillsborough CA, US
Marina Gelman - San Francisco CA, US
Todd Kinsella - Redwood City CA, US
International Classification:
C07D 401/04
C07D 401/14
C07D 471/04
C07D 487/04
C07D 417/04
C07D 417/14
C07F 7/08
A61K 45/06
A61K 31/635
A61K 39/395
C07K 16/28
A61K 31/517
A61K 31/519
A61K 31/5377
A61K 31/4439
A61K 31/444
A61K 31/695
C07D 405/14
Abstract:
The invention described herein comprises compounds of formula (IV) and a method of treating cancer comprising administering to a subject having cancer one of the compounds in conjunction with another therapeutic treatment of cancer. The compounds (IV) inhibit signaling by a member of the TGF-β superfamily such as Nodal or Activin.
Control profile
Marina Y Gelman from San Francisco, CA, age ~65 Get Report